Alvotech announced its inclusion in the Nasdaq Biotechnology Index, effective December 23, 2024, as part of the index’s annual reconstitution. This inclusion is expected to enhance Alvotech’s ...
Alvotech, a biotech company focused on developing biosimilar medicines, announced its inclusion in the Nasdaq Biotechnology Index (NBI) as part of the index's annual reconstitution, effective ...